Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency.

Source:http://linkedlifedata.com/resource/pubmed/id/19324976

Download in:

View as

General Info

PMID
19324976